News | January 25, 2024
Aarti Drugs posts Q3 FY24 consolidated PAT at Rs. 36.71 Cr
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Demonstrate significant bleed reduction in hemophilia A and B
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
The company expects that this development could improve the strength of its application to the FDA for new drug approval
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Subscribe To Our Newsletter & Stay Updated
